The Clinical Significance of CD4 Counts in Asian and Caucasian HIV-Infected Populations: Results from TAHOD and AHOD
Open Access
- 20 April 2011
- journal article
- other
- Published by SAGE Publications in Journal of the International Association of Physicians in AIDS Care
- Vol. 10 (3) , 160-170
Abstract
The significance of interethnic variation in CD4 counts between Asian and Caucasian populations is not known. Patients on combination antiretroviral therapy from Treat Asia and Australian HIV Observational Databases (TAHOD, predominantly Asian, n = 3356; and AHOD, predominantly Caucasian, n = 2312, respectively) were followed for 23 144 person-years for AIDS/death and all-cause mortality endpoints. We calculated incidence-rates and used adjusted Cox regression to test for the interaction between cohort (TAHOD/AHOD) and time-updated CD4 count category (lagged by 3 months) for each of the endpoints. There were 382 AIDS/death events in TAHOD (rate: 4.06, 95%CI: 3.68-4.50) and 305 in AHOD (rate: 2.39, 95%CI: 2.13-2.67), per 100 person-years. At any given CD4 count category, the incidence-rates of endpoints were found to be similar between TAHOD and AHOD (in the adjusted models, P > .05 for the interaction term between cohort type and latest CD4 counts). At any given CD4 count, risk of AIDS or death was not found to vary by ethnicity, suggesting that the CD4 count thresholds for predicting outcomes defined in Caucasian populations may be equally valid in Asian populations.Keywords
This publication has 33 references indexed in Scilit:
- Correcting Mortality for Loss to Follow-Up: A Nomogram Applied to Antiretroviral Treatment Programmes in Sub-Saharan AfricaPLOS Medicine, 2011
- Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patientsAIDS, 2010
- Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-AnalysisPLOS ONE, 2009
- CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionAIDS, 2008
- Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV‐infected patientsHIV Medicine, 2007
- Establishing CD4 Thresholds for Highly Active Antiretroviral Therapy Initiation in A Cohort of HIV-Infected Adult Chinese in Hong KongAIDS Patient Care and STDs, 2007
- Low CD4 T Cell Counts before HIV‐1 Seroconversion Do Not Affect Disease Progression in Ethiopian Factory WorkersThe Journal of Infectious Diseases, 2005
- Impact of Hepatitis C Virus on Immune Restoration in HIV-Infected Patients Who Start Highly Active Antiretroviral Therapy: A Meta-analysisClinical Infectious Diseases, 2005
- Normal Values for CD4 and CD8 Lymphocyte Subsets in Healthy Chinese Adults from ShanghaiClinical and Vaccine Immunology, 2004
- Establishment of Adult Peripheral Blood Lymphocyte Subset Reference Range for an Asian Population by Single-Platform Flow Cytometry: Influence of Age, Sex, and Race and Comparison with Other Published StudiesClinical and Vaccine Immunology, 2004